Zimmer Biomet03.13.19
Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, is showcasing its latest commercial offerings and previewing its next generation of technological innovations this week at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Las Vegas, Nev.
“In addition to our commitment to advancing our traditional implant offering, Zimmer Biomet is transforming the patient journey through an ecosystem of differentiated solutions to provide more personalized care for the patient,” said Bryan C. Hanson, president and CEO of Zimmer Biomet. “We’re looking forward to unveiling at AAOS our latest innovation, ROSA Knee, which leverages over 10 years of robotics experience and offers a differentiated, effective and efficient approach to robotic total knee surgery.”
Among the solutions being showcased at the Zimmer Biomet booth (#2443) are:
ROSA Robotic Technology
With the recent CE Mark approval and U.S. Food and Drug Administration clearance of the ROSA Knee System, Zimmer Biomet expands its robotic platform across multiple surgical disciplines. ROSA Knee is a surgeon-driven system designed to help optimize the accuracy and efficiency of planning and executing a total knee replacement. The system features both X-Atlas 2D X-ray to 3D imaging technology and imageless capabilities providing intraoperative, real-time feedback about the patient’s unique anatomy and soft tissues.
Zimmer Biomet mymobility
Zimmer Biomet mymobility is a care management system on a patient’s wrist that uses the iPhone and Apple Watch to facilitate a new level of connection between patients and their surgical care teams. By collecting and monitoring objective data about the patients’ surgical preparation and recovery, mymobility with Apple Watch helps surgeons deliver better support and guidance to their patients throughout their surgical journey.
Persona The Personalized Knee System
The Persona brand family now offers a seamless platform of partial, primary and revision implants incorporating premium technologies and modern, intuitive instrumentation. The Persona Partial Knee provides compartment-specific shapes, fine sizing increments and reduced surgical steps. The Persona Primary Trabecular Metal Tibia addresses cementless knee applications by combining all the benefits of the Persona design with Zimmer Biomet’s 20-year porous fixation technology. The Persona Revision Knee System completes the Persona platform offering anatomic components designed to match a patient’s unique anatomy for a personalized fit and surgical technique options to accommodate the surgeon’s preferred approach. The Persona Complete Knee System represents the next era in personalization, equipping surgeons with a comprehensive system of implants and instruments that are designed to offer an uncompromising fit and efficiency in the operating room.
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
The company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet has operations in more than 25 countries worldwide and sells products in over 100 countries.
“In addition to our commitment to advancing our traditional implant offering, Zimmer Biomet is transforming the patient journey through an ecosystem of differentiated solutions to provide more personalized care for the patient,” said Bryan C. Hanson, president and CEO of Zimmer Biomet. “We’re looking forward to unveiling at AAOS our latest innovation, ROSA Knee, which leverages over 10 years of robotics experience and offers a differentiated, effective and efficient approach to robotic total knee surgery.”
Among the solutions being showcased at the Zimmer Biomet booth (#2443) are:
ROSA Robotic Technology
With the recent CE Mark approval and U.S. Food and Drug Administration clearance of the ROSA Knee System, Zimmer Biomet expands its robotic platform across multiple surgical disciplines. ROSA Knee is a surgeon-driven system designed to help optimize the accuracy and efficiency of planning and executing a total knee replacement. The system features both X-Atlas 2D X-ray to 3D imaging technology and imageless capabilities providing intraoperative, real-time feedback about the patient’s unique anatomy and soft tissues.
Zimmer Biomet mymobility
Zimmer Biomet mymobility is a care management system on a patient’s wrist that uses the iPhone and Apple Watch to facilitate a new level of connection between patients and their surgical care teams. By collecting and monitoring objective data about the patients’ surgical preparation and recovery, mymobility with Apple Watch helps surgeons deliver better support and guidance to their patients throughout their surgical journey.
Persona The Personalized Knee System
The Persona brand family now offers a seamless platform of partial, primary and revision implants incorporating premium technologies and modern, intuitive instrumentation. The Persona Partial Knee provides compartment-specific shapes, fine sizing increments and reduced surgical steps. The Persona Primary Trabecular Metal Tibia addresses cementless knee applications by combining all the benefits of the Persona design with Zimmer Biomet’s 20-year porous fixation technology. The Persona Revision Knee System completes the Persona platform offering anatomic components designed to match a patient’s unique anatomy for a personalized fit and surgical technique options to accommodate the surgeon’s preferred approach. The Persona Complete Knee System represents the next era in personalization, equipping surgeons with a comprehensive system of implants and instruments that are designed to offer an uncompromising fit and efficiency in the operating room.
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
The company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet has operations in more than 25 countries worldwide and sells products in over 100 countries.